AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The Business Research Company’s Live Attenuated Polio Vaccine Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, June 18, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034
The live attenuated polio vaccine market size has seen formidable growth in recent years, with an increase from $1.85 billion in 2024 to an expected $2.00 billion in 2025. This impressive compound annual growth rate CAGR of 8.3% throughout this historic period was primarily driven by mass immunization campaigns, the emergence of vaccine-derived poliovirus concerns, government immunization programs, and public awareness and education, as well as improvements in vaccine accessibility and affordability.
So, How Is This Live Attenuated Polio Vaccine Market Projected To Expand In The Coming Years?
The upward momentum in the live attenuated polio vaccine market size is anticipated to continue, estimating to reach $2.71 billion in 2029. With a predicted CAGR of 7.9%, this growth is attributed to improved vaccine stability and shelf life, a resurgence of polio cases in conflict zones, donor fatigue in eradication efforts, expansion of routine immunization programs, and increased R&D for safer live attenuated vaccine strains. Major trends in the forecast period include the emergence of vaccine-derived poliovirus, the development of oral polio vaccine, technological advancements in vaccine formulations, the integration of digital technologies, and public-private partnerships.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24280&type=smp
What Are The Primary Factors Driving This Anticipated Live Attenuated Polio Vaccine Market Growth?
The robust expansion of immunization programs is expected to be a key market driver. Immunization programs, primarily organized by governments, health organizations, or other institutions to prevent the spread of infectious diseases, have seen a surge primarily due to increased global awareness of the importance of disease prevention. This, together with strong government support and the backing of international health organizations and funding bodies, has led to a boom in immunization efforts. For example, between 2021 and 2022, global coverage for the first dose of the diphtheria-tetanus-pertussis DTP vaccine expanded from 86% to 89%, as reported by the US-based Centers for Disease Control and Prevention in October 2023.
Who Are The Key Players When It Comes To The Live Attenuated Polio Vaccine Market?
The live attenuated polio vaccine market is powered by industry titans like Sanofi Pasteur, GlaxoSmithKline plc, LG Chem Ltd., Serum Institute of India Pvt. Ltd., Biological E. Limited, Indian Immunologicals Limited, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Vabiotech, Emergent BioSolutions Inc., Valneva SE, Bio Farma, PT Bio Farm, Bilthoven Bio, Panacea Biotec, Haffkine Biopharmaceutical, Panacea Biotec Ltd., Zydus Cadila, Liaoning Cheng Da Biotechnology Co.Ltd, and Bharat Biotech International Limited.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/live-attenuated-polio-vaccine-global-market-report
What Are The Emerging Trends In The Live Attenuated Polio Vaccine Market?
These major companies in live attenuated polio vaccine market have been focusing on obtaining regulatory approvals to ensure their vaccines meet the safety and efficacy standards required by global health authorities. One instance of this was when India-based pharmaceutical and biologics company, Biological E, received approval from the World Health Organization WHO in July 2024 for its novel oral polio vaccine type 2 nOPV2. This next-generation live vaccine is engineered to mitigate the challenges associated with traditional vaccines.
How Is The Live Attenuated Polio Vaccine Market Segmented?
The live attenuated polio vaccine market is segmented by:
1 Vaccine Type: Monovalent, Bivalent, Trivalent
2 Administration Route: Oral Administration, Intramuscular Injection, Subcutaneous Injection
3 Age Group: Infants 0-1 years, Children 1-5 years, Adults Above 5 years
4 End-User: Hospitals, Clinics, Public Health Agencies, Other End-Users
Subsegments include:
1 Monovalent: mOPV1 For Serotype 1
2 Bivalent: Type 1, Type 3
3 Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3
And What Does The Regional Overview Look Like In The Live Attenuated Polio Vaccine Market?
North America held the largest share of the live attenuated polio vaccine market in 2024 with Asia-Pacific expected to be the fastest-growing region in the forecast period. Additional regions covered in this report include Western Europe, Eastern Europe, South America, the Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Therapeutic BCG Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Porcine Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
Vaccine Adjuvants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report
About The Business Research Company:
Learn More About The Business Research Company. With over 15000+ reports covering 27 industries across 60+ geographies, The Business Research Company offers comprehensive, data-rich research and insights. With 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, making informed decisions and staying ahead of the game has never been easier.
To learn more, connect with us at:
The Business Research Company: Websitehttps://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email: [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
